Spiremed Pharmaceuticals Private Limited
About Spiremed Pharmaceuticals Private Limited
Data last updated:
Spiremed Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 12 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24249MH2019PTC321028. Its GSTIN is 36ABBCS5794G1ZZ (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saritha Kola and Suryadevara Praveen.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at # 103/104 1st Floor Orbit Plaza New Prabhadevi Marg, Mumbai, Maharashtra, India – 400025.
As per the financials filed for FY 2024, the company reported a revenue of ₹90.38 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹1.97 Lakh (net margin 2.2%) and EBITDA of ₹2.9 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Spiremed Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address# 103/104 1st Floor Orbit Plaza New Prabhadevi Marg, Mumbai, Maharashtra, India – 400025
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Spiremed Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Spiremed Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Spiremed Pharmaceuticals Private Limited, buy the company report.
Financials of Spiremed Pharmaceuticals Private Limited
FY 2024 filings availableSpiremed Pharmaceuticals Private Limited reported revenue of ₹90.38 Lakh (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 35% over three years, including 17% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spiremed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Spiremed Pharmaceuticals Private Limited
Spiremed Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saritha Kola | Director | 12 Feb 2019 | 7 Years 8 Months | Current |
| Suryadevara Praveen | Director | 12 Feb 2019 | 7 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Spiremed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spiremed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Spiremed Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABBCS5794G1ZZ | Telangana | Active | 26 Apr 2019 |
To see the full GST registrations and return filing status of Spiremed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Spiremed Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Saritha Kola was appointed as Director on 12 Feb 2019.
Frequently asked questions
Spiremed Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 12 February 2019 (7+ years old) and is registered under CIN U24249MH2019PTC321028.
Spiremed Pharmaceuticals has 2 current directors:
- Saritha Kola - Director
- Suryadevara Praveen - Director
The latest financial statements of Spiremed Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Spiremed Pharmaceuticals is 36ABBCS5794G1ZZ, registered in Telangana.
The CIN (Corporate Identification Number) of Spiremed Pharmaceuticals is U24249MH2019PTC321028. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spiremed Pharmaceuticals was incorporated on 12 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Saritha Kola was appointed as Director on 12 Feb 2019. Suryadevara Praveen was appointed as Director on 12 Feb 2019.
The registered office of Spiremed Pharmaceuticals is at # 103104 1st Floor Orbit Plaza New Prabhadevi Marg, Mumbai, Maharashtra, India – 400025.
Spiremed Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Spiremed Pharmaceuticals is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.